Posted on Thursday, January 24, 2013 at 2:01 pm CST
World Moto Inc. (OTCQB: FARE) shows neutral trend as the stock made a sharp movement in its latest trading session. It opened the session at $0.12 and remained in $0.08 and $0.17 price range during the session so far. The stock is 5.41 percent higher at $0.12. World Moto’s first resistance level is at $0.15.
Source: Investor Alley Inc.
Posted on Thursday, January 24, 2013 at 1:37 pm CST
Swingplane Ventures Inc. (OTCQB: SWVI) stock is currently at $0.28, down 4.42 percent from its previous close of $0.29, with high volumes. Its latest trading volume has been recorded at 8.925 million shares. The stock opened the session at $0.30 which is also its highest price point for the session so far. Swingplane Ventures stock’s lowest price point for the session stood at $0.27. The stock’s MACD chart shows neutral trend and the stock may test its first support level at $0.25.
Source: Investor Alley Inc.
Posted on Thursday, January 24, 2013 at 1:16 pm CST
Cisco Systems, Inc. (NASDAQ: CSCO) has agreed to buy Israeli software maker Intucell for $475 million in cash and retention-based incentives, as the technology heavyweight looks to address the challenges brought about by increased network traffic.
Source: Investor Alley Inc.
Posted on Thursday, January 24, 2013 at 12:58 pm CST
Wells Fargo on maintained its Outperform rating on Intel Corporation (NASDAQ: INTC) and its price target in the range between $28 and $33 a share.
Source: Investor Alley Inc.
Posted on Thursday, January 24, 2013 at 11:30 am CST
Organovo Holdings Inc. (PINKSHEETS: ONVO) moved up following the announcement that the Company has entered into an assignment agreement with Mid Americas Group. As per it, the Company was to acquire all of the rights under an option agreement between Mid Americas Group and Gunter Stromber and Elsa Dorila Durate Horta, where Mid Americas has the rights to acquire 75% of certain mining concessions in China.
Source: Investor Alley Inc.
Posted on Thursday, January 24, 2013 at 10:45 am CST
Dell Inc. (NASDAQ: DELL) owner and chief executive, Michael Dell and private equity company Silver Lake Partners work to find co-investors for the deal, which could be valued at almost $25bn.
Source: Investor Alley Inc.
Posted on Thursday, January 24, 2013 at 10:42 am CST
World Moto, Inc. (OTCQB: FARE) is bullish after World Moto, Inc. announced that the Company has successfully closed a private placement for total proceeds of $1m on Jan 11th.
Source: Investor Alley Inc.
Posted on Thursday, January 24, 2013 at 8:22 am CST
SWINGPLANE VENTURES (OTCQB: SWVI) moved up following the announcement that the Company has entered into an assignment agreement with Mid Americas Group. In par with the terms of the agreement, the Company was to acquire all of the rights under an option agreement between Mid Americas Group and Gunter Stromber and Elsa Dorila Durate Horta, where Mid Americas has the rights to acquire 75% of certain mining concessions in China.
Source: Investor Alley Inc.
Posted on Wednesday, January 23, 2013 at 4:52 pm CST
Pharmaceuticals Inc. (NASDAQ:ACAD) stock is at $5.81, up 2.45 percent from its previous close of $5.67. However, its today’s volume of 3.809 million shares is higher than its usual trading volume of 3.237 million shares. The stock opened the session at $6.00 and touched its highest price point at $6.19. Acadia Pharmaceuticals stock’s lowest price point for the session stood at $5.80. The stock’s MACD chart shows bullish trend in the short term. Its first resistance level is at $6.50. Acadia Pharmaceuticals develops small molecule drugs for treating neurological disorders.
Source: Investor Alley Inc.
Posted on Wednesday, January 23, 2013 at 4:50 pm CST
Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) is trading in the range of $3.46 and $3.92 in its current trading session. The stock recorded the volume of 4.453 million shares, in comparison its average daily trading volume of 1.285 million shares. The stock had opened at $3.49 and is at $3.83, up 13.99 percent from its previous close of $3.36. Keryx Biopharmaceuticals has its first support level at $3.23 while it faces the resistance at $4.03. If the stock breaches this level, it may go as high as $4.10. Keryx Biopharmaceuticals is based out of New York and develops therapies for treating renal cancer.
Source: Investor Alley Inc.